According to Cel-Sci 's latest financial reports and stock price the company's current number of shares outstanding is 48,470,600. At the end of 2023 the company had 48,470,600 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 48.47 M | 11.58% |
2022 | 43.44 M | 0.84% |
2021 | 43.07 M | 11.4% |
2020 | 38.67 M | 10.22% |
2019 | 35.08 M | 25.37% |
2018 | 27.98 M | 140.49% |
2017 | 11.63 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 2,407,200,000 | 4,866.31% | ๐บ๐ธ USA |
Amgen AMGN | 535,000,000 | 1,003.76% | ๐บ๐ธ USA |
Xencor XNCR | 60,621,534 | 25.07% | ๐บ๐ธ USA |
Curis CRIS | 5,720,789 | -88.20% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | 1,121,000,000 | 2,212.74% | ๐ฎ๐ฑ Israel |
BioCryst Pharmaceuticals
BCRX | 189,644,000 | 291.26% | ๐บ๐ธ USA |
Emergent BioSolutions
EBS | 51,800,000 | 6.87% | ๐บ๐ธ USA |
Eterna Therapeutics ERNA | 5,410,000 | -88.84% | ๐บ๐ธ USA |